Matsuzuka, Takashi, Tsukahara, Kiyoaki, Yoshimoto, Seiichi, Chikamatsu, Kazuaki, Shiotani, Akihiro, Oze, Isao, Murakami, Yoshiko, Shinozaki, Takeshi, Enoki, Yuichiro, Ohba, Shinichi, Kawakita, Daisuke, Hanai, Nobuhiro, Koide, Yusuke, Sawabe, Michi, Nakata, Yusuke, Fukuda, Yujiro, Nishikawa, Daisuke, Takano, Gaku, Kimura, Takahiro, and Oguri, Keisuke
This sentinel node (SN) biopsy trial aimed to assess its effectiveness in identifying predictive factors of micrometastases and to determine whether elective neck dissection is necessary in oral squamous cell carcinoma. This retrospective study included 55 patients from three previous trials, with positive SNs. The relationship between the sizes of the metastatic focus and metastasis in non-sentinel node (NSN) was investigated. Four of the 55 largest metastatic focus were isolated tumor cells, and the remaining 51 were ranged from 0.2 to 15 mm, with a median of 2.6 mm. The difference of prevalence between 46 negative- and 9 positive-NSN was statistically significant with regard to age, long diameter of primary site and number of cases with regional recurrence. In comparing the size of largest metastatic focus dividing the number of positive SN, with metastaic focus range of < 3.0 mm in one-positive SN group, there were 18 (33%) negative-NSN and no positive-NSN. Regarding prognosis, 3-year overall survival rate of this group (n = 18) and other (n = 37) were 94% and 73% (p = 0.04), and 3-year recurrence free survival rate of this group and other were 94% and 51% (p = 0.03), respectively. Absolutely a further prospective clinical trial would be needed, micrometastases may be defined as solitary SN metastasis with < 3.0 mm of metastatic focus, and approximately 33% of neck dissections could be avoided using these criteria. [ABSTRACT FROM AUTHOR]